Biotechnology makes a significant contribution to core European Union policy goals including public health, ageing society, economic growth, job creation, sustainable development, and environmental protection. Its broad range of high-tech applications is increasingly playing a role in enhancing the EU's competitiveness, raising economic growth and improving the welfare of European citizens.
Only the original language version is authentic and it prevails in the event of its differing from the translated versions.
||Generic and title
||Non-GM and GM maize which look identicalJOINT RESEARCH CENTRE, ISPRA, ITALYThe European Commission's Joint Research Centre (JRC) provides scientific and technical support to policy development, under the EC regulatory framework for Genetically Modified Organisms (GMOs), and for the development of biotechnology expertise in areas relevant to health and consumer protection. It exercises the mandate of the Community Reference Laboratory for GM Food and Feed and of the Community Reference Laboratory for GMOs.
||GMO testing: DNA extraction from corn leaves using nitrogen (7 shots)
||Preparing gel for DNA visualisation which is a DNA based GMO detection method (8 shots)
||DNA sequence analysis (6 shots)
||Test: high protein based GMO detection method (3 shots)
||Microchip test (or chip): it is a detection method based on an instrument to monitor interactions between a receptor cell and specific molecules (5 shots)
||Michael Oredsson, CEO of Probi AB, enters the lab - Lund, Sweden (2 shots)Probi is a Swedish biotechnology company that develops and sells probiotics for use in the food and dietary supplement industries. It was founded in 1991 by doctors in search of a treatment for people with gastro-intestinal diseases. The probiotics that were used as medicine were incorporated into different kinds of food, such as juices and yogurts, as well as in nutritional supplements. The company is part of the Øresund region food cluster.
||Michael Oredsson at the lab, supervising employee's work testing juices with probiotics (5 shots)
||Testing samples of probiotic products (3 shots)
||Lab workers counting bacteria with a machine by tapping dots on the surface of the small bacteria container (6 shots)
||Exterior shot, Agrenvec - Madrid, Spain (2 shots)Agrenvec is a biotech company specialised in producing plant-based mammalian antibodies and protein recombinants. The advantage of these 100% animal-free recombinants is that there is no risk of bacteria or virus contamination. Agrenvec was founded by scientist Isabel Bronchalo and has 14 employees. Isabel is a member of the board in the Association of Biotech companies in Madrid Region, many of which are SMEs such as Agrenvec.
||Researchers working at the lab (4 shots)
||Quality control; researcher testing if the proteins produced by the lab have the activity they are supposed to have (2 shots)
||Researcher taking plants out of a refrigerator (2 shots)
||Plants receiving a drop of recombinant plant virus (3 shots)
||Lab worker separating the plants and using a mortar to grind them with the recombinant (6 shots)
||Plant mixture being filtered (2 shots) - it will then go through a centrifuge so that the protein of about 80% can be obtained
||Protein being placed inside a machine that will verify the level of purity of the proteins and get rid of the impurity that is present (5 shots)
||Two researchers putting the final product in a refrigerator so that it's stored and preserved (2 shots)